10th Annual Best Places to Work in Medical Sales survey polled over 2,000 professionals.
A new survey by MedReps, a career site for medical sales representatives, has revealed that Syneos Health, Teleflex, and Acella & Avion Pharmaceuticals as the overall best medical sales companies to work for in 2021.
The 10th Annual Best Places to Work in Medical Sales survey polled over 2,000 professionals from the MedReps community to identify which medical sales companies are currently the most sought-after in the industry.
The survey results also identified the qualities and values most important to medical sales reps today, which led to them voting for their favorite company. For 2021, medical sales reps reported that they value work-life balance (80%), a focus on team building and collaboration (56%), and a commitment to diversity and inclusion (26%).
Syneos Health, on the list for the 2nd year in a row, recognizes motivated and engaged employees are the single biggest driver of their success. At the core of everything they do, the executive leadership fosters a culture focused on open communication, transparency, and active engagement of employees at all levels of the organization.
“In a year full of uncertainties, companies really stepped up to make their employees happy,” commented Karyn Mullins, president at MedReps. “A record 95% of medical sales respondents say they’re satisfied with their jobs. It seems for many, the difficulties presented by the pandemic made them even more appreciative of the stability and support offered by their employers.”
Findings from the survey include:
For more information about the study, click here.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.